503 related articles for article (PubMed ID: 12381242)
21. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.
Johansson G; Andreasson EB; Larsson PE; Vogelmeier CF
Pharmacoeconomics; 2006; 24(7):695-708. PubMed ID: 16802845
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial.
Wang L; Hollenbeak CS; Mauger DT; Zeiger RS; Paul IM; Sorkness CA; Lemanske RF; Martinez FD; Strunk RC; Szefler SJ; Taussig LM;
J Allergy Clin Immunol; 2011 Jan; 127(1):161-6, 166.e1. PubMed ID: 21211651
[TBL] [Abstract][Full Text] [Related]
23. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
Reynolds NA; Lyseng-Williamson KA; Wiseman LR
Drugs; 2005; 65(12):1715-34. PubMed ID: 16060707
[TBL] [Abstract][Full Text] [Related]
24. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Pavord I; Woodcock A; Parker D; Rice L;
Respir Res; 2007 Sep; 8(1):67. PubMed ID: 17897478
[TBL] [Abstract][Full Text] [Related]
25. A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy.
Bukstein DA; Henk HJ; Luskin AT
Clin Ther; 2001 Sep; 23(9):1589-600. PubMed ID: 11589270
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.
Storms W; Chervinsky P; Ghannam AF; Bird S; Hustad CM; Edelman JM;
Respir Med; 2004 Nov; 98(11):1051-62. PubMed ID: 15526805
[TBL] [Abstract][Full Text] [Related]
27. Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.
Spencer M; Briggs AH; Grossman RF; Rance L
Pharmacoeconomics; 2005; 23(6):619-37. PubMed ID: 15960557
[TBL] [Abstract][Full Text] [Related]
28. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
29. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening AP; Haahtela T; Holgate ST; Picado C; Menten J; Dass SB; Leff JA; Polos PG
BMJ; 2003 Oct; 327(7420):891. PubMed ID: 14563743
[TBL] [Abstract][Full Text] [Related]
30. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
Busse W; Raphael GD; Galant S; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
J Allergy Clin Immunol; 2001 Mar; 107(3):461-8. PubMed ID: 11240946
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
32. Salmeterol/fluticasone propionate: a review of its use in asthma.
McKeage K; Keam SJ
Drugs; 2009; 69(13):1799-828. PubMed ID: 19719334
[TBL] [Abstract][Full Text] [Related]
33. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
Boonsawat W; Goryachkina L; Jacques L; Frith L
Clin Drug Investig; 2008; 28(2):101-11. PubMed ID: 18211118
[TBL] [Abstract][Full Text] [Related]
34. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
Chuchalin A; Jacques L; Frith L
Clin Drug Investig; 2008; 28(3):169-81. PubMed ID: 18266402
[TBL] [Abstract][Full Text] [Related]
35. Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs montelukast.
Orsini L; Limpa-Amara S; Crown WH; Stanford RH; Kamal K
Ann Allergy Asthma Immunol; 2004 May; 92(5):523-9. PubMed ID: 15191020
[TBL] [Abstract][Full Text] [Related]
36. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
37. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
Ostrom NK; Decotiis BA; Lincourt WR; Edwards LD; Hanson KM; Carranza Rosenzweig JR; Crim C
J Pediatr; 2005 Aug; 147(2):213-20. PubMed ID: 16126052
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 microg twice daily and budesonide 800 microg twice daily in the treatment of adults and adolescents with asthma. International Study Group.
Lundbäck B; Jenkins C; Price MJ; Thwaites RM
Respir Med; 2000 Jul; 94(7):724-32. PubMed ID: 10926346
[TBL] [Abstract][Full Text] [Related]
39. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
Nelson HS; Busse WW; Kerwin E; Church N; Emmett A; Rickard K; Knobil K
J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
[TBL] [Abstract][Full Text] [Related]
40. Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.
Camargo CA; Boulet LP; Sutherland ER; Busse WW; Yancey SW; Emmett AH; Ortega HG; Ferro TJ
J Asthma; 2010 Feb; 47(1):76-82. PubMed ID: 20100025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
